| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |